Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments (Jonathan Shieber/TechCrunch)
Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments — With a slew of partnerships with large pharmaceutical companies under its belt and the successful spin out of at least one new company …
via Techmeme
Atomwise, which develops a machine learning-based drug discovery service, raises $123M Series B led by B Capital and Sanabil Investments (Jonathan Shieber/TechCrunch)
![]()
Reviewed by Internet Chicks Blogger
on
August 11, 2020
Rating:
No comments: